Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 8/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | BACE1 | P56817 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6449574 | 1.00 | HCAR2 (0.47) | HCAR2ACHEBACE1TSHRATM | |
| SCHEMBL26966122 | 0.99 | HCAR2 (0.49) | HCAR2ACHEBACE1TSHRGPR84 | |
| SCHEMBL3673917 | 0.99 | HCAR2 (0.49) | HCAR2ACHEBACE1TSHRGPR84 | |
| SCHEMBL26966124 | 0.99 | HCAR2 (0.49) | HCAR2ACHEBACE1TSHRGPR84 | |
| SCHEMBL6453272 | 0.99 | HCAR2 (0.49) | HCAR2ACHEBACE1TSHRGPR84 | |
| SCHEMBL5611261 | 0.99 | HCAR2 (0.49) | HCAR2ACHEBACE1TSHRGPR84 | |
| SCHEMBL3673914 | 0.99 | HCAR2 (0.49) | HCAR2ACHEBACE1TSHRGPR84 | |
| SCHEMBL6453265 | 0.99 | HCAR2 (0.49) | HCAR2ACHEBACE1TSHRGPR84 | |
| SCHEMBL5611266 | 0.99 | HCAR2 (0.49) | HCAR2ACHEBACE1TSHRGPR84 | |
| SCHEMBL6449082 | 0.97 | HCAR2 (0.47) | HCAR2ACHEBACE1TSHRATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1533322-B1 | SOLID CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST | TOHO TITANIUM CO LTD (JP) | 2019-05-01 | — | — | EP | disclosed |
| US-9562119-B2 | Ethylene polymerization catalysts | W. R. GRACE & CO.-CONN. (US) | 2017-02-07 | — | — | US | disclosed |
| EP-2576633-A2 | ETHYLENE POLYMERIZATION CATALYSTS | BASF Corporation (US) | 2013-04-10 | — | — | EP | disclosed |
| US-20110294970-A1 | ETHYLENE POLYMERIZATION CATALYSTS | BASF CATALYSTS, LLC (US) | 2011-12-01 | — | — | US | disclosed |
| WO-2011149656-A2 | ETHYLENE POLYMERIZATION CATALYSTS | BASF CORPORATION (US) | 2011-12-01 | — | — | WO | disclosed |
| US-20050227856-A1 | Solid catalyst component for olefin polymerization and catalyst | TOHO CATALYST CO., LTD. (JP) | 2005-10-13 | — | — | US | disclosed |
| EP-1533322-A1 | SOLID CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST | Toho Catalyst Co., Ltd. (JP) | 2005-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110294970-A1 | ETHYLENE POLYMERIZATION CATALYSTS | ESR1, MSMO1, MCM5 | HCAR2 3524/4885ACHE 820/4885BACE1 3942/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.